99216-67-8

Basic information

• Product Name: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-
• Synonyms: (1R,2R)-(2-Hydroxy-1-hydroxymethyl-propyl)-carbamic acid tert-butyl ester;tert-Butyl ((2R,3R)-1,3-dihydroxybutan-2-yl)carbamate;Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-;N-BOC-L-THREONOL
• CAS NO: 99216-67-8
• Molecular Formula: C₉H₁₉NO₄
• Molecular Weight: 205.25146
• Product Categories: N-BOC
• Mol File: 99216-67-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 366.8°C at 760 mmHg
• Flash Point: 175.6°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 7.22E-07mmHg at 25°C
• Refractive Index: 1.474
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-(99216-67-8)
• EPA Substance Registry System: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-(99216-67-8)

Safety Data

• Hazardous Substances Data: 99216-67-8(Hazardous Substances Data)

Usage

General Description

Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1- is an organic compound with the molecular formula C5H11NO4. It is a carbamic acid derivative with a 1,1 configuration, meaning that the hydroxy and hydroxymethyl groups are positioned in a specific arrangement on the carbon atoms. Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1- is commonly used as a precursor in the synthesis of various pharmaceuticals and agrochemicals. It is also used in the production of carbamate pesticides and in the synthesis of carbamic acid esters. Additionally, it has potential applications in the fields of medicine and biotechnology due to its unique chemical structure and properties.

InChI:InChI=1/C9H19NO4/c1-6(12)7(5-11)10-8(13)14-9(2,3)4/h6-7,11-12H,5H2,1-4H3,(H,10,13)/t6-,7-/m1/s1

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 41840-28-2 S-tert-butoxycarbonyl-4,6-dimethyl-2-mercaptopyrimidine 
• 2592-18-9 Boc-Thr-OH 
• 60538-19-4 N-(tert-butoxycarbonyl)-l-threonine methyl ester 
• 98015-52-2 1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate 
• 3228-51-1 L-threoninol 
• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 

Downstream Products

• 129396-94-7 tert-butyl N-[(1S,2R)-2-hydroxy-1-(phenylsulfanylmethyl)propyl]carbamate 
• 139374-11-1 (2S,3S)-3-Benzyloxycarbonylamino-2-tert-butoxycarbonylamino-butyric acid 2,2,2-trichloro-ethyl ester 
• 99216-74-7 [(1S,2R)-2,3-Bis-(diphenyl-phosphinoyl)-1-methyl-propyl]-carbamic acid tert-butyl ester 
• 99216-69-0 (2R,3S)-1,2-bis(diphenylphosphino)-3-tBoc-aminobutane 
• 139374-05-3 (2R,3S)-3-(benzyloxycarbonyl)amino-2-(t-butoxycarbonyl)amino-1-(t-butyldimethyl)siloxybutane 
• 139374-07-5 (2S,3S)-3-(benzyloxycarbonylamino)-2-(tert-butoxycarbonylamino)butanoic acid 
• 139374-06-4 (2R,3S)-3-(benzyloxycarbonyl)amino-2-(t-butoxycarbonyl)amino-1-butanol 
• 220542-43-8 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,4-dideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-arabino-L-galacto/L-gulo-3-undeculose 
• 213828-84-3 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,4-dideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-arabino-D-manno/D-altro-3-undeculose 
• 220542-46-1 (E)-6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,4,5-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-erythro-L-gluco-undec-4-en-3-ulose 
• 220542-62-1 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,4,5-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-arabino-L-galacto/L-gulo-undecitol 

Relevant articles and documents

Chiral enantiopure organosilane precursors for the synthesis of periodic mesoporous organosilicas

The manuscript describes synthesis of new chiral organosilica networks starting from modified readily available enantiopure substances such as sugars and amino acids. We report on the successful preparation of robust all-chiral organosilicas by polymerization of the homochiral monomers. When the homochiral organosilane monomers were polymerized in mixtures of polar organic solvents and water in the presence of hydrochloric acid or tetrabutylammonium fluoride as catalysts, mainly spherical microparticles were obtained due to emulsification of the hydrophobic monomers in these mixtures. Polycondensation of the chiral organosilanes in the presence of Pluronic P123 as a template produced ordered mesoporous networks. The new all-chiral materials were characterized by SEM, STEM, BET, SAXS, IR, NMR and TGA.

IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS

The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.

Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464

FR901464, a natural product isolated from a bacterium source, activates a reporter gene, inhibits pre-mRNA splicing, and shows antitumor activity. We previously reported the development of a more potent analogue, meayamycin, through the total synthesis of